Neurodegenerative disorders, in particular Alzheimer’s disease pose one of the biggest challenges to 21st Century society. Unless an effective, new approach is developed soon, estimated costs by 2030 will be $2 trillion in the USA alone, while the personal impact is incalculable.

However, the disruptive technology of Neuro-Bio Ltd is already suggesting the plausible possibility of two game-changing breakthroughs in the treatment of Alzheimer’s: (a) a blood biomarker with diagnostic and even prognostic potential and (b) an intranasally administered drug that could stabilise cell loss by combatting the pivotal toxin discovered by Neuro-Bio. Whilst either of these steps would amount to a real advance, (a) and (b) together would enable administration of an effective drug ideally at the pre-symptomatic stage: an effective cure.

Neuro-Bio Ltd
Building F5
Culham Science Centre
OX14 3DB
United Kingdom

(+44) 01235 420085

© All Rights Reserved NeuroBio

ArabicChinese (Simplified)EnglishRussian